UPDATE 3-Novartis buys dry eye drug from Takeda for up to $5.3 bln By: Reuters: Company News May 09, 2019 at 05:45 AM EDT * Deal for Shire-developed drug includes 400 Takeda staff (Adds details, comment from analyst) Read More >> Related Stocks: Astrazeneca Plc ADR Johnson & Johnson Mylan Novan Inc Teva Pharmaceutical Industries ADR